Hypertensive and diabetic patients could benefit from diets prepared using low-sodium salt, with blood pressure significantly reduced following an eight-week intervention, findings from a China study showed.
Thailand is “the supplement market” when it comes to introducing new functional ingredienst into the South East Asia region and beyond, says major Japanese dairy and functional ingredients manufacturer Morinaga Milk.
There is strong evidence supporting the blood pressure (BP) lowering action of casein hydrolysate in patients with cardiovascular disease (CVD), according to a recent systematic assessment and meta-analysis of 26 studies.
Read the latest scientific research on health and nutrition, including a new trial assessing the effects of vitamin D, zinc supplementation in COVID-19 patients, as well as the use of defatted rice and berries for glucose control.
The intake of defatted rice has been shown to improve blood pressure and glycated haemoglobin (HbA1c) levels in overweight and obese adults, according to a 12-week RCT conducted in Thailand.
A comprehensive new meta-analysis underpins previous evidence and adds further credence to the positive impact of omega-3 fatty acids (n-3 PUFAs) on high blood pressure (BP).
Turmeric has been found to improve blood pressure, weight and BMI among nonalcoholic fatty liver disease (NAFLD) patients effectively and improve sirtuin 1 (SIRT1) levels – a key metabolic regulator of glucose and lipid haemostasis.
There has been a slew of product innovation surrounding gamma-aminobutyric acid – better known as GABA – in Japan, with the ingredient incorporated in an array of dosage formats under the Foods with Function Claims (FFCs) framework.
Researchers in Australia are currently recruiting volunteers for an RCT to study the effects of a diet high in prebiotics on blood pressure, as they seek to build on previous pre-clinical findings.
Intake of soy milk has been found to reduce blood pressure, cholesterol levels and inflammation markers in adults, according to a study conducted by researchers in Iran.
Black cumin (Nigella sativa) has been shown to produce therapeutic benefit on key metabolic health markers, namely the reduction of blood pressure, improving lipid profiles and glycaemic control.
OptiBiotix Health will start distributing its blood pressure and cholesterol lowering probiotic in Asia Pacific this year, with heart health concerns rising on the back of changing dietary and lifestyle patterns in the region.
Morinaga Confectionery is launching a new product under Japan’s Foods with Functional Claims (FFC), with a stick-type cocoa powder that is reported to help lower blood pressure and improve bowel movements
British researchers suggest that the consumption of tart cherry, either in capsule or juice format, may reduce the risk of type 2 diabetes or cardiovascular disease by improving cardio-metabolic markers.
Specific metabolites produced by the oral microbiome may be the reason behind the success of diets that have been shown to lower blood pressure, an expert in vascular pharmacology has suggested.
Taiwanese supplement manufacturer Phermpep, which produces kefir-based finished products and ingredients for improved bone and heart health, will launch in its first international markets later this year.
Resveratrol supplementation could provide heart benefits for people with type 2 diabetes by alleviating arterial stiffness and lowering oxidative stress, a Japanese study has found.
The types of fruit juices that appear to offer the most help in tackling cardiovascular disease and aiding weight management have been highlighted in a new academic review.
